Protein arginine methyltransferases in renal development, injury, repair, and fibrosis

Jianjun Yu1, Chao Yu1, Georgia Bayliss2

  • 1Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

Frontiers in Pharmacology
|February 23, 2023
PubMed

Insights

Protein arginine methyltransferases (PRMTs) regulate kidney development, injury, and fibrosis. This review summarizes their roles and mechanisms in renal processes, highlighting potential clinical applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • Protein arginine methyltransferases (PRMTs) are enzymes involved in gene transcription and post-translational modifications.
  • Most research on PRMTs has focused on their roles in cancer and other organs.
  • Increasing evidence highlights PRMT expression and function within the kidney.

Purpose of the Study:

  • To review the function and mechanisms of PRMTs in renal development.
  • To summarize the involvement of PRMTs in kidney injury and repair processes.
  • To explore the potential of PRMTs for future clinical applications in nephrology.

Main Methods:

  • Literature review of studies on PRMTs in kidney physiology and pathology.
  • Analysis of mechanisms by which PRMTs regulate renal gene expression.
  • Examination of PRMTs' roles in histone and non-histone substrate methylation within the kidney.

Main Results:

  • PRMTs are expressed in the kidney and play critical roles in renal development.
  • PRMTs are implicated in the pathogenesis of kidney injury and fibrosis.
  • Specific PRMTs influence various stages of renal repair mechanisms.

Conclusions:

  • PRMTs are key regulators of diverse renal processes, including development, injury, repair, and fibrosis.
  • Understanding PRMT mechanisms in the kidney offers therapeutic targets.
  • PRMTs represent a promising area for clinical intervention in kidney diseases.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K